RHON-KLINIKUM AG has announced a stable business performance for the first half of 2026, with consolidated revenue reaching EUR 863.6 million, a slight increase from EUR 833.5 million in the prior year period. EBITDA rose to EUR 57.0 million (H1 2025: EUR 46.7 million), and consolidated profit improved to EUR 22.5 million (H1 2025: EUR 14.7 million). The company treated 513,700 patients across its hospitals and medical care centers, a 9% increase compared to the same period last year.
The results were significantly impacted by immediate transformation costs established to offset higher personnel and material costs from previous years. Despite these costs, the company continues to invest in expanding regional health networks, which it sees as vital for the future of healthcare. In Hesse, Universitatsklinikum Marburg and Lungenfachklinik Immenhausen have formed a strategic partnership to improve care for lung patients. In Brandenburg, the newly opened child protection emergency service at the Frankfurt (Oder) site is part of a strong regional network, with cooperation agreements between the hospital, the city, and the district ensuring coordinated help for affected children and adolescents.
Dr. Gunther K. WeiB, member of the Board of Management, emphasized the importance of regional networks: “Regional networks form a vital and essential part of any future healthcare system. Rigid sectoral boundaries make it more difficult to provide patients with the care they need and saddle our healthcare system with unnecessary costs. It is only when general practitioners, specialists, medical facilities, nurses and therapists work together as a team that we can pool our resources efficiently. In the face of mounting pressures, such collaboration across providers is the only way to ensure comprehensive and high-quality care to patients, especially in rural areas.”
However, the company expressed concerns about new legislation. Dr. Stefan Stranz, also a member of the Board of Management, stated: “The Statutory Health Insurance Contribution Rate Stabilization Act imposes further burdens on hospitals. Instead of reducing bureaucracy and refocusing on patient care, the reform saddles already overburdened hospitals with even more documentation requirements, excessive budget cuts, and financial risks.”
For the full year 2026, RHON-KLINIKUM expects revenues of EUR 1.7 billion within a range of plus or minus 5%, and EBITDA between EUR 110 million and EUR 125 million. The company also anticipates a moderate improvement in non-financial indicators such as number of cases and cost weights. However, the forecast is subject to significant uncertainties due to the unfolding legislation process. The Hospital Reform Adjustment Act (KHAG), which came into force on 15 April 2026, and the SHI Contribution Rate Stabilisation Act (GKV-BStabG), adopted on 10 July 2026, aim to improve quality and efficiency but are expected to increase financial pressure on hospitals in the short term.
The company notes that ongoing global crises and negative economic impacts are causing higher prices, supply bottlenecks, and general market volatility, making it difficult to reliably forecast the overall impact of regulatory interference and further legislative adjustments.
